Goldenpeak Fund I, L.P.
£375 million
“Specialist UK partner investing in high-growth B2B services companies.”
November 2025
Saothair Fund II, L.P.
$300 million
“Lower middle market complex corporate carveouts and special situations.”
June 2025
Sundance Growth Fund I, L.P.
$125 million
“Sundance Growth is a software growth equity firm investing in emerging, global B2B SaaS companies with less than $10 million in ARR, providing strategic capital to accelerate growth.”
June 2025
Ren Life Sciences Partners I, L.P.
€210 million
“Backing Europe’s fastest growing Life Science businesses in their journey to get better science into patients faster, and build Life Science jobs in Europe.”
April 2025
Cuadrilla Capital Fund II, L.P.
$300 million
“Control-oriented enterprise
SaaS investments.”
September 2024
StoneTree Investment Partners Fund I, L.P.
$155 million
“Established niche manufacturing and industrial companies where we can serve alongside employees to elevate the company.”
July 2024
Seven Hills Capital Fund I, L.P.
$125 million
“Building practitioner-led healthcare services businesses focused on complex and/or underserved consumers and markets.”
December 2023
Saothair Fund I, L.P.
$125 million
“Lower middle market complex corporate carveouts and special situations.”
October 2023
Care Equity II, L.P.
$302 million
“Focus on accelerating
health care innovation.”
October 2022
Cuadrilla Capital Fund I, L.P.
“Control-oriented enterprise
SaaS investments.”
September 2022
Rallyday Partners Fund II, L.P.
$205 million
“Empowering inspired companies
with inspired capital.”
March 2022
Nosara Capital Fund II, L.P.
$150 million
“Thematic and concentrated early-stage investment strategy focused on online marketplaces.”
March 2022
Care Equity, L.P.
$125 million
“Specialized private equity fund focused on companies in the life science and care delivery ecosystems.”
December 2020
Rallyday Partners Fund I, L.P.
$150 million
“Empowering inspired companies
with inspired capital.”
March 2020
Goldenpeak Fund I, L.P.
£375 million
“Specialist UK partner investing in high-growth B2B services companies.”
November 2025
Saothair Fund II, L.P.
$300 million
“Lower middle market complex corporate carveouts and special situations.”
June 2025
Sundance Growth Fund I, L.P.
$125 million
“Sundance Growth is a software growth equity firm investing in emerging, global B2B SaaS companies with less than $10 million in ARR, providing strategic capital to accelerate growth.”
June 2025
Ren Life Sciences Partners I, L.P.
€210 million
“Backing Europe’s fastest growing Life Science businesses in their journey to get better science into patients faster, and build Life Science jobs in Europe.”
April 2025
Cuadrilla Capital Fund II, L.P.
$300 million
“Control-oriented enterprise
SaaS investments.”
September 2024
StoneTree Investment Partners
Fund I, LP
$155 million
“Established niche manufacturing and industrial companies where we can serve alongside employees to elevate the company.”
July 2024
Seven Hills Capital Fund I, L.P.
$125 million
“Building practitioner-led healthcare services businesses focused on complex and/or underserved consumers and markets.”
December 2023
Saothair Fund I, L.P.
$125 million
“Lower middle market complex corporate carveouts and special situations.”
October 2023
Care Equity II, L.P.
$302 million
“Focus on accelerating
health care innovation.”
October 2022
Cuadrilla Capital Fund I, L.P.
“Control-oriented enterprise
SaaS investments.”
September 2022
Rallyday Partners Fund II LP
$205 million
“Empowering inspired companies
with inspired capital.”
March 2022
Nosara Capital Fund II, L.P.
$150 million
“Thematic and concentrated early-stage investment strategy focused on online marketplaces.”
March 2022
Care Equity, L.P.
$125 million
“Specialized private equity fund focused on companies in the life science and care delivery ecosystems.”
December 2020
Rallyday Partners Fund I LP
$150 million
“Empowering inspired companies
with inspired capital.”
March 2020